versión imprimible
 
 

Interstitial Lung Disease Drug Development Summit

Evvnt Promotion / evvnt
-
27.04.2021 - 29.04.2021  Online
Time: 09:00 - 15:00
 
Temas de la conferencia
With the entire world's attention focused firmly on pulmonary fibrosis in the wake of COVID19 and the landmark INBUILD study dramatically overhauling the ILD drug development landscape, biopharma are finally on the cusp of developing and disseminating life-changing therapeutics for patients suffering with interstitial lung disease.
Organizador profesional (PCO)
Hanson Wade
Observaciones
Speakers: Ahmad Nabhan, Postdoctoral Scholar, Genentech, Christina Wenglen, Head of Research, AnaMar, Craig Conoscenti, Medical Expert ILD Respiratory Clinical Development and Medical Affairs, Boehringer Ingelheim and more.
 

Información e inscripción:

https://go.evvnt.com/729096-2?pid=4832
Mr. Customer Service
 
Categorías
Medicina General
Idioma
Inglés
Cuota del Congreso
Conference + Workshops Day - Industry: $2799.0, Conference Only - Industry: $1999.0, Workshop Day - Industry: $899.0, Conference + Workshops Day - Academic: $1899.0, Conference Only - Academic: $1299.0, Workshops Day - Academic: $699.0
Los participantes esperaban
1000
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

OÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Österreichische Akademie der ÄrzteÖsterreichische Gesellschaft für Public HealthSwiss Tropical and Public Health InstituteAGEM - Arbeitsgemeinschaft Ethnologie und MedizinAnästhesie in Entwicklungsländern e. V.European Health Forum GasteinÄrztekammer für Wien